Drug name: Midazolam
Section 5: Anticonvulsants/antiepileptics
Oral liquid: 5 mg/ml
Application prepared by:
Professor Emilio Perucca, M.D, Ph.D., Head, Clinical Trial Center, Institute of Neurology IRCCS C Mondino Foundation, Via Mondino, 27100 Pavia, Italy, and Professor of Medical Pharmacology, Department of Internal Medicine and therapeutics, University of Pavia, Piazza Botta 10, 27100 Pavia, Italy.